The investigation by Lei et al. further proved that evaluated expression levels of hnRNPA2B1 promoted exosomal levels of H19 secreted by gefitinib-resistance cells of NSCLC (Lei et al., 2018). The gene discussed is H19; the disease is non-small cell lung carcinoma.